Stilbenes reduce staphylococcus aureus hemolysis, biofilm formation, and virulence

Foodborne Pathogens and Disease

Volumn 11, Issue 9, 2014, Pages 710-717

  Lee, Kayeon ^a   Lee, Jin Hyung ^a   Ryu, Shi Yong ^b   Cho, Moo Hwan ^a   Lee, Jintae ^a  

^a Yeungnam University   (South Korea)

^b Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HEMOLYSIN; RESVERATROL; STILBENE DERIVATIVE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BACTERIAL TOXIN; HEMOLYSIN; STAPHYLOCOCCAL ALPHA-TOXIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BIOFILM; CAENORHABDITIS ELEGANS; CELL ADHESION; CONTROLLED STUDY; DRUG INHIBITION; ERYTHROCYTE; GENE LOCUS; HEMOLYSIS; HLA SYSTEM; HUMAN; HUMAN CELL; IN VIVO STUDY; NONHUMAN; STAPHYLOCOCCUS AUREUS; ANIMAL; CHEMISTRY; DRUG EFFECTS; GENETICS; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; STAPHYLOCOCCAL INFECTIONS; VIRULENCE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TOXINS; BIOFILMS; CAENORHABDITIS ELEGANS; HEMOLYSIN PROTEINS; HEMOLYSIS; HUMANS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STILBENES; VIRULENCE;

EID: 84906983077     PISSN: 15353141     EISSN: 15567125     Source Type: Journal    
DOI: 10.1089/fpd.2014.1758     Document Type: Article

References (34)

1. Augustine N, Goel AK, Sivakumar KC, Kumar RA, Thomas S. Resveratrol-A potential inhibitor of biofilm formation in Vibrio cholerae. Phytomedicine 2014;21:286-289.
2. Begun J, Gaiani JM, Rohde H, Mack D, Calderwood SB, Au-subel FM, Sifri CD. Staphylococcal biofilm exopoly-saccharide protects against Caenorhabditis elegans immune defenses. PLoS Pathog 2007;3:e57.
3. Bhakdi S, Tranum-Jensen J. Alpha-toxin of Staphylococcus aureus. Microbiol Rev 1991;55:733-751.
4. Boles BR, Horswill AR. Agr-mediated dispersal of Staphylo-coccus aureus biofilms. PLoS Pathog 2008;4:e1000052.
5. Bubeck Wardenburg J, Schneewind O. Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med 2008;205:287-294.
6. Burns J, Yokota T, Ashihara H, Lean ME, Crozier A. Plant foods and herbal sources of resveratrol. J Agric Food Chem 2002;50:3337-3340.
7. Cegelski L, Marshall GR, Eldridge GR, Hultgren SJ. The biology and future prospects of antivirulence therapies. Nat Rev Microbiol 2008;6:17-27.
8. Choi CW, Choi YH, Cha MR, Kim YS, Yon GH, Hong KS, et al. In vitro BACE-1 inhibitory activity of resveratrol oligomers from the seed extract of Paeonia lactiflora. Planta Med 2011;77:374-376.
9. Coenye T, Brackman G, Rigole P, De Witte E, Honraet K, Rossel B, Nelis HJ. Eradication of Propionibacterium acnes biofilms by plant extracts and putative identification of icar-iin, resveratrol and salidroside as active compounds. Phyto-medicine 2012;19:409-412.
10. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science 1999;284: 1318-1322.
11. Cottart CH, Nivet-Antoine V, Laguillier-Morizot C, Beaudeux JL. Resveratrol bioavailability and toxicity in humans. Mol Nutr Food Res 2010;54:7-16.
12. Cramton SE, Gerke C, Schnell NF, Nichols WW, Götz F. The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun 1999;67:5427-5433.
13. Cushman M, Nagarathnam D, Gopal D, Chakraborti AK, Lin CM, Hamel E. Synthesis and evaluation of stilbene and dihy-drostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization. J Med Chem 1991;34:2579-2588.
14. Hentzer M, Riedel K, Rasmussen TB, Heydorn A, Andersen JB, Parsek MR, et al. Inhibition of quorum sensing in Pseudo-monas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiology 2002;148:87-102.
15. Iwase T, Uehara Y, Shinji H, Tajima A, Seo H, Takada K, et al. Staphylococcus epidermidis Esp inhibits Staphylococcus au-reus biofilm formation and nasal colonization. Nature 2010;465:346-349.
16. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275:218-220.
17. Larzábal M, Mercado EC, Vilte DA, Salazar-González H, Cataldi A, Navarro-Garcia F. Designed coiled-coil peptides inhibit the type three secretion system of enteropathogenic Escherichia coli. PLoS ONE 2010;5:e9046.
18. Lee J-H, Cho MH, Lee J. 3-Indolylacetonitrile decreases Es-cherichia coli O157:H7 biofilm formation and Pseudomonas aeruginosa virulence. Environ Microbiol 2011;13:62-73.
19. Lee J-H, Cho HS, Kim Y-G, Kim J-A, Banskota S, Cho MH, Lee J. Indole and 7-benzyloxyindole attenuate the virulence of Staphylococcus aureus. Appl Microbiol Biotechnol 2013a; 97:4543-4552.
20. Lee J-H, Joo SW, Regmi SC, Kim A-J, Ryu C-M, Ryu SY, et al. Diverse plant extracts and trans-resveratrol inhibit biofilm formation and swarming of Escherichia coli O157:H7. Biofouling 2013b;29:1189-1203.
21. Levy SB, Marshall B. Antibacterial resistance worldwide: Causes, challenges and responses. Nat Med 2004;10:S122-S129.
22. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998;339:520-532.
23. Murphy CT, McCarroll SA, Bargmann CI, Fraser A, Kamath RS, Ahringer J, et al. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 2003;424:277-283.
24. Ohlsen K, Koller KP, Hacker J. Analysis of expression of the alpha-toxin gene (hla) of Staphylococcus aureus by using a chromosomally encoded hla:lacZ gene fusion. Infect Immun 1997;65:3606-3614.
25. Park J, Jagasia R, Kaufmann GF, Mathison JC, Ruiz DI, Moss JA, et al. Infection control by antibody disruption of bacterial quorum sensing signaling. Chem Biol 2007;14:1119-1127.
26. Selma MV, Larrosa M, Beltrán D, Lucas R, Morales JC, Tomás-Barberán F, Espín JC. Resveratrol and some glucosyl, glucosylacyl, and glucuronide derivatives reduce Escherichia coli O157:H7, Salmonella Typhimurium, and Listeria monocytogenes scott A adhesion to colonic epithelial cell lines. J Agric Food Chem 2012;60:7367-7374.
27. Sifri CD, Begun J, Ausubel FM, Calderwood SB. Cae-norhabditis elegans as a model host for Staphylococcus au-reus pathogenesis. Infect Immun 2003;71:2208-2217.
28. Sotheeswaran S, Pasupathy V. Distribution of resveratrol olig-omers in plants. Phytochemistry 1993;32:1083-1092.
29. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet 2001;358: 135-138.
30. Vom Saal FS, Timms BG, Montano MM, Palanza P, Thayer KA, Nagel SC, et al. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci USA 1997;94:2056-2061.
31. Weston SA, Parish CR. New fluorescent dyes for lymphocyte migration studies: Analysis by flow cytometry and fluorescence microscopy. J Immunol Methods 1990;133:87-97.
32. Wilke GA, Bubeck Wardenburg J. Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus a-hemolysin-mediated cellular injury. Proc Natl Acad Sci USA 2010; 107:13473-13478.
33. Wyatt MA, Wang W, Roux CM, Beasley FC, Heinrichs DE, Dunman PM, Magarvey NA. Staphylococcus aureus non-ribosomal peptide secondary metabolites regulate virulence. Science 2010;329:294-296.
34. Zgoda-Pols JR, Freyer AJ, Killmer LB, Porter JR. Antimicrobial resveratrol tetramers from the stem bark of Vatica oblongifolia ssp oblongifolia. J Nat Prod 2002;65:1554-1559.